| 000 | 01728 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514181155.0 | ||
| 264 | 0 | _c20040423 | |
| 008 | 200404s 0 0 eng d | ||
| 022 | _a0066-4804 | ||
| 024 | 7 |
_a10.1128/AAC.48.3.765-773.2004 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAzoulay-Dupuis, E | |
| 245 | 0 | 0 |
_aActivities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model. _h[electronic resource] |
| 260 |
_bAntimicrobial agents and chemotherapy _cMar 2004 |
||
| 300 |
_a765-73 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Infective Agents _xpharmacology |
| 650 | 0 | 4 |
_aDNA Gyrase _xgenetics |
| 650 | 0 | 4 |
_aDNA Topoisomerase IV _xgenetics |
| 650 | 0 | 4 | _aDrug Resistance, Bacterial |
| 650 | 0 | 4 |
_aFluoroquinolones _xpharmacology |
| 650 | 0 | 4 |
_aLung _xmicrobiology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aNaphthyridines _xpharmacology |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aPneumonia, Pneumococcal _xblood |
| 650 | 0 | 4 |
_aQuinolines _xpharmacology |
| 650 | 0 | 4 |
_aStreptococcus pneumoniae _xdrug effects |
| 650 | 0 | 4 | _aSurvival Analysis |
| 700 | 1 | _aBédos, J P | |
| 700 | 1 | _aMohler, J | |
| 700 | 1 | _aPeytavin, G | |
| 700 | 1 | _aIsturiz, R | |
| 700 | 1 | _aMoine, P | |
| 700 | 1 | _aRieux, V | |
| 700 | 1 | _aCherbuliez, C | |
| 700 | 1 | _aPéchère, J C | |
| 700 | 1 | _aFantin, B | |
| 700 | 1 | _aKöhler, T | |
| 773 | 0 |
_tAntimicrobial agents and chemotherapy _gvol. 48 _gno. 3 _gp. 765-73 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/AAC.48.3.765-773.2004 _zAvailable from publisher's website |
| 999 |
_c14704047 _d14704047 |
||